Two of the commonly used coronavirus vaccines provide protection against multiple variants of the virus that causes COVID-19, including the highly infectious Delta variant, a new Yale study has found.
- October 08, 2021
One especially important role of physicians, Wang believes, is to be supportive of their patients. Even if there is not much a physician can physically do, for Wang earning a patient’s trust is powerful in itself.
- October 06, 2021
The National Cancer Institute has recognized Markus Müschen, MD, PhD, with its Outstanding Investigator Award.
- October 01, 2021
We are excited to welcome Dhruvi Shah as a postgraduate associate jointly working in our lab and the Joshi Lab in Immunobiology! Dhruvi completed an integrated Msc. in Cell and Molecular Biology at the Maharaja Sayajirao University of Baroda in Vadodara, India, studying energy pathways in macrophage polarization. In the lab, she will be using organoid models to study how obesity shapes anti-tumor immunity in pancreatic cancer.
- September 27, 2021Source: The New York Times
Chemotherapy for decades was considered “the rule, the dogma,” for treating breast cancer and other cancers. But data from a variety of sources offers some confirmation of what many oncologists say anecdotally — the method is on the wane for many cancer patients.
- September 15, 2021
As part of a new program introduced by the Center for Community Engagement and Health Equity (CEHE) at Yale Cancer Center, and in partnership with the Community Alliance for Research and Engagement (CARE), nine community members from New Haven joined five research groups at Yale Cancer Center for a 9-month Fellowship in 2021 to bring community perspectives to cancer research and to learn about cancer research at Yale.
- September 14, 2021
Pilot Grants Now Available Through Yale Diabetes Research Center
- September 02, 2021
In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters.
- September 02, 2021
When it comes to long-lasting protection against COVID-19, antibodies — proteins created by B cells to neutralize invading pathogens — are our biggest allies, a new Yale study shows.
- September 02, 2021Source: YaleNews
When it comes to long-lasting protection against COVID-19, antibodies are our biggest allies, a new Yale University study shows.